CXCR4 and head and neck squamous cell carcinoma: A recent investigation demonstrated that two types of nanotoxins equipped with T22 peptide ligands display potent CXCR4-dependent cytotoxic effects in vitro, and possess the ability to selectively target HNSCC cells that overexpress CXCR4.